FDA Approves Neffy, the First Needle-Free Epinephrine Nasal Spray for Anaphylaxis

Neffy offers a pain-free, easy-to-use alternative to traditional EpiPens for treating severe allergic reactions.

Neffy is approved for adults and children weighing at least 66 pounds.
The nasal spray provides a single dose of epinephrine, with a second dose possible if symptoms persist.
Neffy is expected to be available in the U.S. within eight weeks at a cost of $199 for two doses.
Patients with insurance may pay as little as $25 per prescription through co-pay savings programs.
The approval addresses the fear of needles, particularly in children, and aims to improve rapid treatment of anaphylaxis.